| アブストラクト | Drug-induced acute kidney injury (AKI) can occur both in primary care (i.e., community-acquired AKI (CA-AKI)) and in hospital settings (i.e., hospital-acquired AKI (HA-AKI)). The reported prevalence of these events varies markedly from one study to another, mainly due to differences in the study design. To estimate the frequency of drug-induced AKIs (both CA-AKIs and HA-AKIs) observed in a French university hospital, we applied the capture-recapture method to 1) the French national pharmacovigilance database (FPVD) and 2) a cohort of hospitalized patients with drug-induced AKIs (documented by analyzing the French national hospital discharge database and the patients' electronic medical records). Drug-induced AKIs were determined according to the Naranjo algorithm and then categorized as CA-AKIs or HA-AKIs. A total number of 1,557 episodes of AKI were record during the study period, of them, the estimated total number of drug-induced AKIs was 593 [95% confidence interval (CI): 485-702], and the estimated prevalence was 38.1% [95%CI: 35.67-40.50]. The prevalences of HA-AKIs and CA-AKIs were similar (39.4% [36.24-42.54] and 37.4% [33.67-41.21], respectively). Only 6.1% of the drug-induced AKIs were recorded in the FPVD, and the proportions of recorded HA-AKIs and CA-AKI differed markedly (3.0% vs. 10.5%, respectively). One of the most frequently involved drug classes were antibiotics in the HA-AKI subgroup (13.0%) and antineoplastics in the CA-AKI subgroup (8.3%). Application of the capture-recapture method to two incomplete data sources can improve the ability to identify and quantify adverse drug reactions like AKIs. The frequency of drug-induced AKI is relatively high and is probably underestimated. The clinical management of an AKI might depend on where it originated. |
|---|
| ジャーナル名 | Frontiers in pharmacology |
|---|
| 投稿日 | 2022/7/23 |
|---|
| 投稿者 | Rey, Amayelle; Gras, Valerie; Moragny, Julien; Choukroun, Gabriel; Masmoudi, Kamel; Liabeuf, Sophie |
|---|
| 組織名 | Division of Clinical Pharmacology, Pharmacoepidemiology Department, Amiens;University Hospital, Amiens, France.;MP3CV Laboratory, EA7517, Jules Verne University of Picardie, Amiens, France.;Division of Nephrology, Amiens University Hospital, Amiens, France. |
|---|
| Pubmed リンク | https://www.ncbi.nlm.nih.gov/pubmed/35865950/ |
|---|
